However, KRAS p.G12V was also described recently in ovarian clear cell carcinoma via whole exome sequencing [39], though this subtype is mainly characterized by frequent activating mutations in PIK3CA and infrequent mutations in KRAS [40]. This evidence concerns the gene KRAS and ovarian clear cell cancer.